Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

U.S. bans imports of certain Apple Watches that may infringe on patented pulse readers

by December 28, 2023
December 28, 2023
U.S. bans imports of certain Apple Watches that may infringe on patented pulse readers

The U.S. has officially banned imports of certain Apple Watch models after the Biden administration declined to veto an agency’s decision to restrict the products.

The affected watches come with a pulse oximeter feature that reads blood-oxygen levels. Apple has included the feature in every watch since its 2020 Series 6 model.

At issue is a complaint by the California-based medical monitoring technology company Masimo that the pulse reader feature infringes on its pulse-oximeter technology, which is designed to monitor blood oxygen levels.

In October, the U.S. International Trade Commission ruled that the Apple products must be excluded from the U.S. marketplace based on evidence of infringement. That decision, which went into effect Tuesday, would have needed a presidential veto to be overturned.

Apple ended direct U.S. sales of affected Ultra 2 and Series 9 watches last week.

In a statement, Apple said it is appealing the trade commission decision, though it already rejected a request to pause the ban during the appeals process. Apple is also suing Masimo.

The Apple Watch SE will continue to be sold directly by Apple.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Workers wrested a seat at the table on AI this year. Will it be enough?
next post
Additional Assays from El Pilar, Cuba

Related Posts

Google forcing some remote workers to come back...

April 24, 2025

Home foreclosures are rising nationwide, with Florida, California...

June 12, 2023

Judge allows lawsuit over Burger King’s Whopper ads...

May 8, 2025

Playboy moving its headquarters to Miami Beach and...

August 17, 2025

Paramount and Skydance inch closer to a merger...

April 30, 2024

DeepSeek hit with large-scale cyberattack, says it’s limiting...

January 28, 2025

New sports bundle could give cord-cutting fans their...

February 8, 2024

UAW president warns new walkouts could happen at...

October 16, 2023

AMC bets on premium screens as Hollywood slate...

April 1, 2025

Boeing’s latest 737 Max failure narrowly avoided tragedy...

January 10, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • CHARBONE Appoints Patrick Cuddihy as Senior Vice President – Strategic Affairs

    • TERRA CLEAN CLOSES $2.5 MILLION LIFE OFFERING

    • Noble Minerals Acquires a Rare Earth Property in Northern Quebec

    • Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

    • Freegold Intersects 3.63 g/t Au over 45.4m at Golden Summit

    Categories

    • Business (1,408)
    • Investing (3,117)
    • Politics (3,699)
    • Stocks (1,841)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved